Science: Cancer Vaccine on the Horizon

Society | April 8, 2005, Friday // 00:00

A pioneering vaccine against the virus that causes cervical cancer and genital warts has been proved highly effective, according a recent scientific report.

The vaccine, produced by the drug company Merck & Co., was found to cut dramatically the infection rate of human papillomavirus (HPV), the cause of cervical cancer and genital warts, for both by 90% in a small-scale trial.

Gardasil, which could reach the market in 2006, is designed to protect women against four strains of the human papillomavirus (HPV).

Cervical cancer affects some 470,000 women a year and survival chances are good if the disease is detected and treated early.

The findings, published in the The Lancet Oncology, put pharmaceutical giants Merck & Co Inc ahead in the race to market the world's first anti-cancer vaccine.

We need your support so Novinite.com can keep delivering news and information about Bulgaria! Thank you!

Society » Be a reporter: Write and send your article

Advertisement
Advertisement
Bulgaria news Novinite.com (Sofia News Agency - www.sofianewsagency.com) is unique with being a real time news provider in English that informs its readers about the latest Bulgarian news. The editorial staff also publishes a daily online newspaper "Sofia Morning News." Novinite.com (Sofia News Agency - www.sofianewsagency.com) and Sofia Morning News publish the latest economic, political and cultural news that take place in Bulgaria. Foreign media analysis on Bulgaria and World News in Brief are also part of the web site and the online newspaper. News Bulgaria